Amgen Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.2
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
AMGN
High-quality business with 106% return on equity and 21% profit margins.
⚠ high leverage at 6.4× debt-to-equity.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $352.73 (+1.2%)
30 analysts
HOLD
Target $29.00 (+8.3%)
27 analysts
Fundamentals
AMGN
PFE
24.5×
Trailing P/E
19.7×
14.9×
Forward P/E
9.5×
21.0%
Profit Margin
12.4%
70.8%
Gross Margin
75.8%
106.1%
ROE
8.9%
8.6%
Revenue Growth
-1.2%
112.1%
Earnings Growth
—
0.47
Beta
0.39
—
Price / Book
—
$187.9B
Market Cap
$152.3B
$261 – $391
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.